Imaging PARP with [18F]rucaparib in pancreatic cancer models
2022 · European Journal of Nuclear Medicine and Molecular Imaging · 23 citations
https://doi.org/10.1007/s00259-022-05835-4
D
Doreen Lau
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.6K
Citations
19
h-index
25
i10-index
Doreen Lau is an academic researcher from University of Cambridge. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Medical Imaging Techniques and Applications & Immunotherapy and Immune Responses. The author has an h-index of 19, co-authored 38 publications.
ORCID: 0000-0002-7623-2401Papers by this author
worksThe emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
2020 · Nuclear Medicine and Biology · 15 citations
https://doi.org/10.1016/j.nucmedbio.2020.06.005
Clinical Translation of Neutrophil Imaging and Its Role in Cancer
2021 · Molecular Imaging and Biology · 15 citations
https://doi.org/10.1007/s11307-021-01649-2
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
2022 · EJNMMI Research · 13 citations
https://doi.org/10.1186/s13550-022-00940-9
Unraveling the cartography of the cancer ecosystem
2021 · Genome biology · 6 citations
https://doi.org/10.1186/s13059-021-02310-5
Identification and characterization of the vertebrate motile ciliome
2012 · Cilia · 1 citations
https://doi.org/10.1186/2046-2530-1-s1-o10
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat